Journal of Interventional Cardiac Electrophysiology

, Volume 25, Issue 2, pp 129-133

First online:

Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia

  • Mauricio ArrudaAffiliated withElectrophysiology Section, University Hospitals Harrington-McLaughlin Heart and Vascular Institute, Case Western Reserve University School of Medicine Email author 
  • , Luciana ArmaganijanAffiliated withHamilton Health Sciences
  • , Tamer FahmyAffiliated withDepartment of Critical Care Medicine, Cairo University
  • , Luigi Di BiaseAffiliated withTexas Cardiac Arrhythmias Institute
  • , Dimpi PatelAffiliated withTexas Cardiac Arrhythmias Institute
  • , Andrea NataleAffiliated withTexas Cardiac Arrhythmias Institute

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Arrhythmogenic right ventricular dysplasia (ARVD) is a progressive, genetically determined fibro-fatty infiltrative myocardial disease with an estimated prevalence in the general population to be 1:5,000 to 1:10,000. ARVD leads to electrical instability that may predispose to life-threatening ventricular arrhythmia, heart failure, and sudden death. We reviewed the pathological substrate for ventricular arrhythmias, ECG findings and treatment modalities in ARVD. Importantly, novel techniques such as electroanatomic and voltage mapping has greatly improved the identification of the scared substrate in the settings of ARVD and have improved safety and efficacy of VT ablation procedures associated with this entity.


Catheter ablation Arrhythmogenic right ventricular dysplasia ARVD Ablation in arrhythmogenic right ventricular dysplasia